M Holdings Securities’s Orchestra BioMed OBIO Stock Holding History

M Holdings Securities’s Portfolio OBIO Stock Details OBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-19,850	Closed	-$162K	–	235
2024 Q2	$162K	Buy	+19,850	New	+$115K	0.02%	289

Other funds holding OBIO

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

M Holdings Securities's OBIO Position: Q3 2024 in Review

M Holdings Securities sold out of Orchestra BioMed (OBIO) in Q3 2024, closing a stake of 19,850 shares — an estimated $162K sold.

M Holdings Securities first reported a position in OBIO in Q2 2024 and held it in 1 quarter. The position peaked at $162K in Q2 2024. 48 funds tracked by Wall St. Rank hold OBIO as of Q3 2024.

M Holdings Securities reported no remaining Orchestra BioMed position as of Q3 2024 after selling out during the quarter.
M Holdings Securities sold 19,850 Orchestra BioMed shares in Q3 2024, an estimated $162K.
M Holdings Securities first reported a position in Orchestra BioMed in Q2 2024 and held it in 1 quarter.
M Holdings Securities's Orchestra BioMed position peaked at $162K in Q2 2024.
48 funds tracked by Wall St. Rank held Orchestra BioMed as of Q3 2024.

Based on M Holdings Securities's 13F filing for Q3 2024, filed 12 Nov 2024.